[go: up one dir, main page]

ES2549309T3 - Formulación terapéutica nueva - Google Patents

Formulación terapéutica nueva Download PDF

Info

Publication number
ES2549309T3
ES2549309T3 ES06101197.9T ES06101197T ES2549309T3 ES 2549309 T3 ES2549309 T3 ES 2549309T3 ES 06101197 T ES06101197 T ES 06101197T ES 2549309 T3 ES2549309 T3 ES 2549309T3
Authority
ES
Spain
Prior art keywords
new therapeutic
therapeutic formulation
transcutaneously
nsaid
administrable
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
ES06101197.9T
Other languages
English (en)
Inventor
Marie Lodén
Ulf Åkerström
Emil Schwan
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Omega Pharma Innovation and Development NV
Original Assignee
Omega Pharma Innovation and Development NV
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Omega Pharma Innovation and Development NV filed Critical Omega Pharma Innovation and Development NV
Application granted granted Critical
Publication of ES2549309T3 publication Critical patent/ES2549309T3/es
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/38—Cellulose; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Inorganic Chemistry (AREA)
  • Dermatology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

Un sistema de administración transcutánea de fármacos que comprende: a. 0,5 al 5 % (p/p) de un fármaco antiinflamatorio no esteroideo (NSAID) fotosensible administrable de manera transcutánea; b. un agente gelificante no iónico seleccionado del grupo de agentes gelificantes de celulosa; c. un disolvente hidrófilo; d. un dióxido de titanio particulado cosméticamente aceptable.

Description

imagen1
imagen2
imagen3
imagen4
imagen5

Claims (1)

  1. imagen1
ES06101197.9T 2005-02-02 2006-02-02 Formulación terapéutica nueva Active ES2549309T3 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SE5002423 2005-02-02
SE0500242 2005-02-02

Publications (1)

Publication Number Publication Date
ES2549309T3 true ES2549309T3 (es) 2015-10-26

Family

ID=36954183

Family Applications (1)

Application Number Title Priority Date Filing Date
ES06101197.9T Active ES2549309T3 (es) 2005-02-02 2006-02-02 Formulación terapéutica nueva

Country Status (7)

Country Link
EP (1) EP1688129B1 (es)
DK (1) DK1688129T3 (es)
ES (1) ES2549309T3 (es)
HU (1) HUE025427T2 (es)
NO (1) NO339644B1 (es)
PL (1) PL1688129T3 (es)
PT (1) PT1688129E (es)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE102006051035A1 (de) * 2006-10-20 2008-04-24 Technische Universität Bergakademie Freiberg Dermatologische Zubereitung und deren Verwendung
ES2363964B1 (es) 2009-11-20 2012-08-22 Gp Pharm, S.A. Cápsulas de principios activos farmacéuticos y ésteres de ácidos grasos poliinsaturados.
CN116165306B (zh) * 2023-04-25 2023-11-17 湖南九典制药股份有限公司 酮洛芬凝胶贴膏中有关物质的分析测定方法及应用

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0228572B2 (ja) * 1981-11-13 1990-06-25 Hisamitsu Pharmaceutical Co Shinkishitsupuzai
JPS59170011A (ja) * 1983-03-16 1984-09-26 Pola Chem Ind Inc 日焼け防止化粧料
JPS59170114A (ja) * 1983-03-18 1984-09-26 Toray Ind Inc エポキシ系微粒子およびその製造方法
GB8712752D0 (en) 1987-05-30 1987-07-01 Tioxide Group Plc Particulate material
GB8829402D0 (en) 1988-12-16 1989-02-01 Tioxide Group Plc Dispersion
AU8927191A (en) * 1990-10-05 1992-04-28 Analgesic Associates Prevention or treatment of sunburn using the s(+) isomer of flurbiprofen
CA2093359A1 (en) * 1990-10-05 1992-04-06 Abraham Sunshine Prevention or treatment of sunburn using the s(+) isomer of ketoprofen
GB9204387D0 (en) 1992-02-29 1992-04-15 Tioxide Specialties Ltd Oil-in-water emulsions
JPH09169658A (ja) 1995-12-19 1997-06-30 Pola Chem Ind Inc 抗炎症皮膚外用剤
FR2804024B1 (fr) 2000-01-21 2002-09-13 Menarini France Nouvelles compositions pharmaceutiques a action anti- inflammatoire et leur procede de preparation

Also Published As

Publication number Publication date
PL1688129T3 (pl) 2016-03-31
HUE025427T2 (en) 2016-02-29
NO339644B1 (no) 2017-01-16
EP1688129A1 (en) 2006-08-09
NO20060550L (no) 2006-08-03
DK1688129T3 (en) 2015-10-05
PT1688129E (pt) 2015-11-04
EP1688129B1 (en) 2015-07-08

Similar Documents

Publication Publication Date Title
RU2470642C2 (ru) Аналоги птерина для лечения состояния, чувствительного к вн4
BR0114799A (pt) Compostos de ácido cianofenoxi carboxìlico e composições para liberar agentes ativos
AR054238A1 (es) Composicion farmaceutica que contiene una biguanida y un derivado de tiazolidindiona
DE69906518D1 (de) Arzneistoff-abgabesystem enthaltend eine festgepackte, feste arzneistoffbasis
UY27533A1 (es) Composiciones farmacéuticas que contienen oxibutinina
EA200800161A1 (ru) Новые фармацевтические композиции с модифицированным высвобождением и способ получения таких композиций
ES2545959T3 (es) Un medicamento consistente en un derivado de carboestirilo y donepezilo para el tratamiento de la enfermedad de Alzheimer
AR033168A1 (es) Solucion oral de aripiprazol
CO6331425A2 (es) Composiciones que comprenden n-(3,4-difluoro-2-(2-fluoro-4-yodofenilamino)6-metoxifenil)-1-(2,3-dihidroxiproxipropil)ciclopropan-1-sulfamida
DE60134245D1 (de) (5-(2-hydroxy-4-chlorbenzoyl)valeriansäure und deren salze, und zusammensetzungen zur zuführung von wirkstoffen, die diese verbindungen enthalten
BR0211317A (pt) Sistema para a liberação controlada de uma droga por meio de retenção gástrica
DE69533470D1 (de) Aus mehreren einzeleinheiten zusammengesetztes pharmazeutisches präparat, das einen protonenpumpeninhibitor enthält
BRPI0015567B8 (pt) composto, composição farmacêutica, forma de unidade de dosagem, uso da composição farmacêutica e método para preparar uma composição farmacêutica
NO20011721D0 (no) N-aralkylaminotetraliner som ligander for neuropeptid Y Y5 reseptor
CO5580767A2 (es) Compuestos de indazol y composiciones farmaceuticas para inhibir proteinquinasas y procedimientos para su uso
DE60313359D1 (de) Fenofibratsäure enthaltende pharmazeutische zusammensetzung und deren physiologisch verträgliche salze und derivate
DE50005529D1 (de) Orale darreichungsformen zur verabreichung einer fixen kombination von tramadol und diclofenac
ATE386725T1 (de) Heterocyclylverbindungen
ES2176106B1 (es) Comprimido matricial de liberacion prolongada de trimetazidina tras su administracion por via oral.
AR036658A1 (es) Formulacion de dosificacion oral de fundicion instantanea
ES2549309T3 (es) Formulación terapéutica nueva
FR2850023B1 (fr) Medicaments pour le systeme nerveux
NO20062668L (no) Orale formuleringer av desoxypeganin og anvendelser derav
RU2008147216A (ru) Жидкая лекарственная композиция
PE20051163A1 (es) Formas de dosificacion oral de acido n-(2-(2-ftalimido-etoxi)-acetil)-l-alanil-d-glutamico (lk 423)